Betamethasone Dipropionate
Commercial
Anti-inflammatory
IP/ BP / USP/ EP
5593 – 20 – 4
CEP Planned
ANVISA, KFDA
Application - injections, creams, foams, gels, lotions, ointments, syrups
Drug Description
Betamethasone Dipropionate is the 17,21-dipropionate ester of betamethasone, a synthetic glucocorticoid with metabolic, immunosuppressive and anti-inflammatory actions. Betamethasone dipropionate binds to specific intracellular glucocorticoid receptors and subsequently binds to DNA to modify gene expression. The synthesis of certain anti-inflammatory proteins is induced while the synthesis of certain inflammatory mediators is inhibited. As a result, there is an overall reduction in chronic inflammation and autoimmune reactions.

